TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
TCL Archive Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals March 28, 1997
TCL Archive Bevacizumab Prolongs Survival In Patients With Advanced Colorectal Cancer November 26, 2004